Eagle Pharmaceuticals IPO Research Information

Eagle Pharmaceuticals IPO Advisory

Share this IPO Profile:

Smart Search

For IPO Boutique's "scale of 1 to 5" BUY rating on Eagle Pharmaceuticals, and our comprehensive analysis, click "Buy Market Research".

Company	Symbol	Price Range	Issue Price	Open	Shares	Trade Date
Eagle Pharmaceuticals	EGRX - NASDAQ	$14.00-$16.00	$15.00	$15.50	3.33 million	2/12/2014
Underwriter(s): Piper Jaffray, William Blair
Co-Manager(s): Cantor Fitzgerald & Co.
Industry: Health Care
Filing(s): Filed 2013-12-20

Eagle Pharmaceuticals Quote & Chart - Click for current quote - EGRX

About Eagle Pharmaceuticals (adapted from Eagle Pharmaceuticals prospectus):
They are a specialty pharmaceutical company focused on developing and commercializing injectable products utilizing the FDA's 505(b)(2) regulatory pathway.

This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.

IPO Boutique aggregates information on public companies and private companies, such as "EGRX" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.